You have 9 free searches left this month | for more free features.

Relapser

Showing 1 - 25 of 33

STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS

Chronic Hepatitis C Genotype-1 Relapse Trial in Worldwide (NIM811, Placebo BID + SOC)

Completed
  • Chronic Hepatitis C Genotype-1 Relapse
  • San Diego, California
  • +15 more
Dec 11, 2020

Hepatitis C, Chronic, Opioid-Related Disorders Trial in Germany

Completed
  • Hepatitis C, Chronic
  • Opioid-Related Disorders
    • Munich, Bavaria, Germany
    • +17 more
    Apr 27, 2021

    Hepatitis C Trial (boceprevir, PegIFN-2b, RBV)

    Completed
    • Hepatitis C
    • (no location specified)
    Aug 6, 2018

    Chronic Hepatitis C Infection Trial in United States (Fuzheng Huayu, Placebo)

    Completed
    • Chronic Hepatitis C Infection
    • Fuzheng Huayu
    • Placebo
    • Coronado, California
    • +7 more
    Apr 28, 2021

    Addiction, Cocaine-Related Disorders Trial in Clermont-Ferrand (Virtual Reality-Enhanced Cognitive Behavioral Therapy (VR-CBT),

    Unknown status
    • Addiction
    • Cocaine-Related Disorders
    • Virtual Reality-Enhanced Cognitive Behavioral Therapy (VR-CBT)
    • Treatment as usual
    • Clermont-Ferrand, Auvergne, France
      CHU Clermont Ferrand
    Feb 20, 2020

    HCV, Hepatitis C Infection, Genotype 4 Trial (2 DAA, RBV)

    Completed
    • HCV
    • +2 more
    • (no location specified)
    Jul 28, 2021

    Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Placebo for ABT-450/r/ABT-267)

    Completed
    • Chronic Hepatitis C Infection
    • ABT-450/r/ABT-267, ABT-333
    • +4 more
    • (no location specified)
    Jul 29, 2021

    Chronic Hepatitis C Virus (HCV) Infection Genotype 1 Trial in United States (ABT-450/r/ABT-267, ABT-333, Ribavirin (RBV))

    Completed
    • Chronic Hepatitis C Virus (HCV) Infection Genotype 1
    • Phoenix, Arizona
    • +47 more
    Jun 27, 2022

    Chronic HCV Infection Trial in Clermont-Ferrand (Elbasvir/Grazoprevir Fixed Dose Combination)

    Completed
    • Chronic HCV Infection
    • Elbasvir/Grazoprevir Fixed Dose Combination
    • Clermont-Ferrand, France
      CHU Clermont-Ferrand
    Sep 9, 2020

    Very Rapid and Rapid Virological Response as Predictors of

    Unknown status
    • Predictors of Response to HCV Tretment
      • (no location specified)
      Jul 5, 2018

      Chronic Hepatitis C Infection Trial (ABT-450/r/ABT-267, ABT-333, Ribavirin, Pegylated Interferon a-2a (PegINF))

      Completed
      • Chronic Hepatitis C Infection
      • ABT-450/r/ABT-267, ABT-333
      • +3 more
      • (no location specified)
      May 2, 2018

      Hepatitis C Trial in Belgium, France (TMC435)

      Completed
      • Hepatitis C
      • Antwerpen, Belgium
      • +7 more
      Jul 5, 2017

      Hepatitis C, Chronic Trial in Kaohsiung (Stop trial intervention for boceprevir, PEG-IFN and RBV)

      Completed
      • Hepatitis C, Chronic
      • Stop trial intervention for boceprevir, PEG-IFN and RBV
      • Kaohsiung, Taiwan
        Hepatitis Center and Hepatobiliary Division, Department of Inter
      Mar 12, 2018

      Chronic Hepatitis C Infection Trial (ombitasvir/paritaprevir/ritonavir and dasabuvir, ribavirin)

      Completed
      • Chronic Hepatitis C Infection
      • ombitasvir/paritaprevir/ritonavir and dasabuvir
      • ribavirin
      • (no location specified)
      Jul 5, 2017

      Hepatitis C, Chronic Trial in Worldwide (PegIFN/RBV, BI201335, BI201335 24W)

      Completed
      • Hepatitis C, Chronic
      • Birmingham, Alabama
      • +70 more
      Jul 28, 2016

      Hepatitis C, Chronic Trial in Worldwide (BI 201335, Pegylated Interferon-alpha (IFN), Ribavirin (RBV))

      Completed
      • Hepatitis C, Chronic
      • BI 201335
      • +3 more
      • North Little Rock, Arkansas
      • +115 more
      Jul 28, 2016

      Chronic Hepatitis C, Genotype 4 Chronic Hepatitis C Trial in Spain (Simeprevir, Sofosbuvir)

      Completed
      • Chronic Hepatitis C
      • Genotype 4 Chronic Hepatitis C
      • Badalona, Spain
      • +6 more
      Sep 28, 2016

      Chronic Hepatitis C Trial in Ann Arbor (Pioglitazone, Placebo Oral Tablet)

      Completed
      • Chronic Hepatitis C
      • Ann Arbor, Michigan
        University of Michigan
      Dec 15, 2016

      Hepatitis C, Chronic Trial in Worldwide (Telaprevir, Pegylated Interferon Alfa-2a, Ribavirin)

      Terminated
      • Hepatitis C, Chronic
      • Birmingham, Alabama
      • +82 more
      May 14, 2015

      Assess Impact of Use of Interferon in Chronic Hepatitis C

      Completed
      • Hepatitis C, Chronic
      • Conventional Interferon
      • +3 more
      • Rio Branco, AC, Brazil
      • +36 more
      Oct 6, 2016

      Relapse in the Treatment of Hepatitis C (Study P05181)

      Completed
      • Hepatitis C, Chronic
        • (no location specified)
        Nov 26, 2015

        Hepatitis C Virus Infection Trial in Japan (Daclatasvir, Asunaprevir, Ribavirin)

        Completed
        • Hepatitis C Virus Infection
        • Nagoya-shi, Aichi, Japan
        • +47 more
        Sep 23, 2015

        Chronic Hepatitis C Trial in Minato-ku (MP-424 (generic name:Telaprevir), Ribavirin, Peginterferon alfa-2b)

        Completed
        • Chronic Hepatitis C
        • MP-424 (generic name:Telaprevir)
        • +2 more
        • Minato-ku, Tokyo, Japan
          Toranomon Hospital
        Oct 29, 2014

        Hepatitis C Trial in Japan (BI 201335 high dose, BI 201335 low dose)

        Completed
        • Hepatitis C
        • BI 201335 high dose
        • BI 201335 low dose
        • Chuo-ku, Chiba, Japan
        • +23 more
        Jul 3, 2015

        Hepatitis C, Chronic Trial in Japan (TMC435, Peginterferon alfa-2b (pegIFN alfa-2b), Ribavirin (RBV))

        Completed
        • Hepatitis C, Chronic
        • Amagasaki, Japan
        • +10 more
        Apr 10, 2014